Literature DB >> 22751991

Managing mesh exposure following vaginal prolapse repair: a decision analysis comparing conservative versus surgical treatment.

Laura C Skoczylas1, Jonathan P Shepherd, Kenneth J Smith, Jerry L Lowder.   

Abstract

INTRODUCTION AND HYPOTHESIS: A decision analysis model was developed comparing conservative and surgical treatments in the management of synthetic mesh exposure following vaginal prolapse repair. We hypothesized that surgical excision would be favored.
METHODS: A Markov decision analysis model compared initial management with conservative versus surgical treatment allowing for the complexities of multiple attempts at conservative management and/or surgical mesh excision. Model assumptions were obtained from published literature or through surrogate values and expert consensus when not available in published resources. Transitions were made between Markov states at 6-week intervals and overall utility was compared over 2 years. Multiple one-way sensitivity analyses were performed.
RESULTS: Initial surgical excision was favored, with an average yearly quality adjusted life year (QALY) value of 0.947 compared to 0.939 for conservative treatment. This difference is less than the published minimally important difference (MID) for utility values. One-way sensitivity analyses revealed that surgical excision is favored when the probability of being healed with conservative therapy is less than 80 % (base case 57.1 %) and when the probability of being healed from surgery is greater than 78 % (base case 93.2 %). Few thresholds confirmed model robustness.
CONCLUSIONS: While our model favored surgical excision over conservative treatment in the initial management of mesh exposure following vaginal prolapse repair with synthetic mesh, the difference in QALYs between strategies was less than the MID. Therefore the strategies are likely similar overall. Individual patient characteristics may ultimately drive clinical decision-making for this surgical complication.

Entities:  

Mesh:

Year:  2012        PMID: 22751991     DOI: 10.1007/s00192-012-1847-3

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  26 in total

1.  Vaginal mesh erosion after transvaginal repair of cystocele using Gynemesh or Gynemesh-Soft in 138 women: a comparative study.

Authors:  X Deffieux; R de Tayrac; C Huel; J Bottero; A Gervaise; K Bonnet; R Frydman; H Fernandez
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-01-04

2.  De novo stress incontinence and pelvic muscle symptoms after transvaginal mesh repair.

Authors:  Matthew J Aungst; Evan B Friedman; Walter S von Pechmann; Nicolette S Horbach; Jeffrey A Welgoss
Journal:  Am J Obstet Gynecol       Date:  2009-04-23       Impact factor: 8.661

Review 3.  Surgical management of pelvic organ prolapse in women: the updated summary version Cochrane review.

Authors:  Christopher M Maher; Benny Feiner; Kaven Baessler; Cathryn M A Glazener
Journal:  Int Urogynecol J       Date:  2011-09-17       Impact factor: 2.894

4.  Transvaginal repair of genital prolapse with polypropylene mesh using a tension-free technique.

Authors:  Rajka B Argirovic; Aleksandra M Gudovic; Ivana R Babovic; Milica V Berisavac
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2010-07-31       Impact factor: 2.435

5.  Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence.

Authors:  A L Olsen; V J Smith; J O Bergstrom; J C Colling; A L Clark
Journal:  Obstet Gynecol       Date:  1997-04       Impact factor: 7.661

6.  Vaginal mesh for prolapse: a randomized controlled trial.

Authors:  Cheryl B Iglesia; Andrew I Sokol; Eric R Sokol; Bela I Kudish; Robert E Gutman; Joanna L Peterson; Susan Shott
Journal:  Obstet Gynecol       Date:  2010-08       Impact factor: 7.661

7.  Complications requiring reoperation following vaginal mesh kit procedures for prolapse.

Authors:  Rebecca U Margulies; Christina Lewicky-Gaupp; Dee E Fenner; Edward J McGuire; J Quentin Clemens; John O L Delancey
Journal:  Am J Obstet Gynecol       Date:  2008-10-09       Impact factor: 8.661

8.  Toward consistency in cost-utility analyses: using national measures to create condition-specific values.

Authors:  M R Gold; P Franks; K I McCoy; D G Fryback
Journal:  Med Care       Date:  1998-06       Impact factor: 2.983

9.  Retrospective multicentre study of the new minimally invasive mesh repair devices for pelvic organ prolapse.

Authors:  M Abdel-Fattah; I Ramsay
Journal:  BJOG       Date:  2008-01       Impact factor: 6.531

10.  Transvaginal repair of genital prolapse: preliminary results of a new tension-free vaginal mesh (Prolift technique)--a case series multicentric study.

Authors:  B Fatton; J Amblard; P Debodinance; M Cosson; B Jacquetin
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-11-28
View more
  4 in total

1.  Vaginal native tissue repair versus transvaginal mesh repair for apical prolapse: how utilizing different methods of analysis affects the estimated trade-off between reoperation for mesh exposure/erosion and reoperation for recurrent prolapse.

Authors:  Alexis A Dieter; Marcella G Willis-Gray; Alison C Weidner; Anthony G Visco; Evan R Myers
Journal:  Int Urogynecol J       Date:  2015-02-03       Impact factor: 2.894

2.  Lower exposure rates of partially absorbable mesh compared to nonabsorbable mesh for cystocele treatment: 3-year follow-up of a prospective randomized trial.

Authors:  J Farthmann; D Watermann; A Niesel; C Fünfgeld; A Kraus; F Lenz; H J Augenstein; E Graf; B Gabriel
Journal:  Int Urogynecol J       Date:  2012-08-29       Impact factor: 2.894

3.  Is antibiotic prophylaxis necessary before midurethral sling procedures for female stress incontinence? A decision analysis.

Authors:  Jonathan P Shepherd; Keisha A Jones; Oz Harmanli
Journal:  Int Urogynecol J       Date:  2013-08-01       Impact factor: 2.894

Review 4.  In vivo response to polypropylene following implantation in animal models: a review of biocompatibility.

Authors:  Michelle Kelly; Katherine Macdougall; Oluwafisayo Olabisi; Neil McGuire
Journal:  Int Urogynecol J       Date:  2016-05-23       Impact factor: 2.894

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.